Skye writing off glaucoma post-phase II, airs obesity plan bioworld.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bioworld.com Daily Mail and Mail on Sunday newspapers.
Cantor Fitzgerald started coverage on shares of Skye Bioscience (NASDAQ:SKYE – Free Report) in a research report released on Thursday, Marketbeat reports. The brokerage issued an overweight rating and a $21.00 price target on the stock. SKYE has been the subject of a number of other research reports. Piper Sandler reissued an overweight rating and […]
Skye Bioscience (NASDAQ:SKYE – Get Free Report) is one of 1,000 publicly-traded companies in the “Pharmaceutical preparations” industry, but how does it compare to its competitors? We will compare Skye Bioscience to similar companies based on the strength of its profitability, dividends, risk, earnings, valuation, institutional ownership and analyst recommendations. Valuation & Earnings This table […]
Skye Bioscience (NASDAQ:SKYE) Posts Earnings Results, Misses Expectations By $0 02 EPS wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.
Skye Bioscience, Inc s (NASDAQ:SKYE) last week s 13% decline must have disappointed private equity firms who have a significant stake yahoo.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from yahoo.com Daily Mail and Mail on Sunday newspapers.